182 related articles for article (PubMed ID: 28232249)
1. J-shaped relationship between supervised methadone consumption and retention in methadone maintenance treatment (MMT) in primary care: National cohort study.
Cousins G; Boland F; Barry J; Lyons S; Keenan E; O'Driscoll D; Bennett K; Fahey T
Drug Alcohol Depend; 2017 Apr; 173():126-131. PubMed ID: 28232249
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with early and later dropout from methadone maintenance treatment in specialist addiction clinics: a six-year cohort study using proportional hazards frailty models for recurrent treatment episodes.
Durand L; Boland F; O'Driscoll D; Bennett K; Barry J; Keenan E; Fahey T; Cousins G
Drug Alcohol Depend; 2021 Feb; 219():108466. PubMed ID: 33421801
[TBL] [Abstract][Full Text] [Related]
3. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
[TBL] [Abstract][Full Text] [Related]
4. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study.
Cao X; Wu Z; Rou K; Li L; Lin C; Wang C; Luo W; Pang L; Yin W; Li J;
Drug Alcohol Depend; 2014 Dec; 145():87-93. PubMed ID: 25448082
[TBL] [Abstract][Full Text] [Related]
5. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
6. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
Morozova O; Dvoriak S; Pykalo I; Altice FL
Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
[TBL] [Abstract][Full Text] [Related]
7. Misconceptions predict dropout and poor adherence prospectively among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China.
Gu J; Xu H; Lau JT; Hao Y; Zhong Y; Fan L; Zhao Y; Hao C; Ling W
Addiction; 2012 Sep; 107(9):1641-9. PubMed ID: 22360534
[TBL] [Abstract][Full Text] [Related]
8. Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China.
Che Y; Assanangkornchai S; McNeil E; Chongsuvivatwong V; Li J; Geater A; You J
Drug Alcohol Rev; 2010 May; 29(3):263-70. PubMed ID: 20565518
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal and case-control study of dropout among drug users in methadone maintenance treatment in Haiphong, Vietnam.
Khue PM; Tham NT; Thanh Mai DT; Thuc PV; Thuc VM; Han PV; Lindan C
Harm Reduct J; 2017 Aug; 14(1):59. PubMed ID: 28854943
[TBL] [Abstract][Full Text] [Related]
11. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.
Hayashi K; Ti L; Ayutthaya PPN; Suwannawong P; Kaplan K; Small W; Kerr T
Harm Reduct J; 2017 Sep; 14(1):63. PubMed ID: 28882155
[TBL] [Abstract][Full Text] [Related]
12. Proportional hazards frailty models for recurrent methadone maintenance treatment.
Nosyk B; MacNab YC; Sun H; Fischer B; Marsh DC; Schechter MT; Anis AH
Am J Epidemiol; 2009 Sep; 170(6):783-92. PubMed ID: 19671835
[TBL] [Abstract][Full Text] [Related]
13. Retention in Georgia opioid substitution therapy program and associated factors.
Ruadze E; Todadze K
Harm Reduct J; 2016 Dec; 13(1):35. PubMed ID: 27931232
[TBL] [Abstract][Full Text] [Related]
14. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
Holland R; Maskrey V; Swift L; Notley C; Robinson A; Nagar J; Gale T; Kouimtsidis C
Addiction; 2014 Apr; 109(4):596-607. PubMed ID: 24304349
[TBL] [Abstract][Full Text] [Related]
15. Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study.
Cousins G; Boland F; Courtney B; Barry J; Lyons S; Fahey T
Addiction; 2016 Jan; 111(1):73-82. PubMed ID: 26234389
[TBL] [Abstract][Full Text] [Related]
16. A national study of the retention of Irish opiate users in methadone substitution treatment.
Mullen L; Barry J; Long J; Keenan E; Mulholland D; Grogan L; Delargy I
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):551-8. PubMed ID: 22747484
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
Strang J; Marsden J; Cummins M; Farrell M; Finch E; Gossop M; Stewart D; Welch S
Addiction; 2000 Nov; 95(11):1631-45. PubMed ID: 11219367
[TBL] [Abstract][Full Text] [Related]
18. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
19. Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.
Zhao Y; Shi CX; McGoogan JM; Rou K; Zhang F; Wu Z
Addiction; 2015 Jan; 110 Suppl 1(Suppl 1):40-50. PubMed ID: 25533863
[TBL] [Abstract][Full Text] [Related]
20. Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review.
Zhou K; Zhuang G
Addict Behav; 2014 Jan; 39(1):22-9. PubMed ID: 24090627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
